Benjamin Halladay Esperion Therapeutics, Inc. (ESPR) insider trading activity

Benjamin Halladay is Chief Financial Officer of Esperion Therapeutics, Inc.. Currently has a direct ownership of 467,525 shares of ESPR, which is worth approximately $1.36 Million. The most recent transaction as insider was on Dec 17, 2025, when has been sold 7,337 shares (Common Stock) at a price of $3.67 per share, resulting in proceeds of $26,926. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 468K

1.55% 3M change

94.24% 12M change

Total Value Held $1.36 Million

Benjamin Halladay Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 17 2025	SELL Open market or private sale	$26,926 $3.67 p/Share	7,337 Reduced 1.55%	467,525 Common Stock
Sep 17 2025	SELL Open market or private sale	$19,799 $2.81 p/Share	7,046 Reduced 1.46%	474,862 Common Stock
Jul 17 2025	SELL Open market or private sale	$12 $1.12 p/Share	11 Reduced 0.0%	474,462 Common Stock
Jun 17 2025	SELL Open market or private sale	$8,313 $1.15 p/Share	7,229 Reduced 1.5%	474,473 Common Stock
Apr 17 2025	SELL Open market or private sale	$7 $0.96 p/Share	8 Reduced 0.0%	481,702 Common Stock
Mar 18 2025	SELL Open market or private sale	$5,231 $1.48 p/Share	3,535 Reduced 0.73%	481,710 Common Stock
Mar 14 2025	BUY Grant, award, or other acquisition	-	238,000 Added 32.91%	485,245 Common Stock

Feb 19 2025	SELL Open market or private sale	$20 $1.86 p/Share	11 Reduced 0.0%	240,671 Common Stock
Jan 17 2025	SELL Open market or private sale	$20 $2.27 p/Share	9 Reduced 0.0%	240,682 Common Stock
Dec 17 2024	SELL Open market or private sale	$7,852 $2.42 p/Share	3,245 Reduced 1.33%	240,691 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	170,000 Added 41.07%	243,936 Common Stock
Mar 14 2023	BUY Grant, award, or other acquisition	-	9,200 Added 11.07%	73,936 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	-	44,000 Added 40.83%	63,771 Common Stock

Benjamin Halladay

Chief Financial Officer

Ann Arbor, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Value

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Esperion Therapeutics, Inc.

Track Activities on ESPR

Account